← FDA Drug Approvals (Drugs@FDA)
ROFLUMILAST
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2020-03-30
Drug application
- FDA Application #
ANDA208247- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ROFLUMILAST
- Generic name
- Roflumilast
- Active ingredients
- ROFLUMILAST
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- STRIDES PHARMA
- First approval
- 2020-03-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown